Chargement en cours...
Study on myelin injury of AD mice treated with Shenzhiling oral liquid in the PI3K/Akt–mTOR pathway
Shenzhiling oral liquid (SZL) is a Traditional Chinese Medicine (TCM) compound to be approved by the China Food and Drug Administration (CFDA) (Z20120010) for the treatment of mild-to-moderate Alzheimer’s disease (AD). However, its mechanism in early AD is not clear. We studied its mechanism in prot...
Enregistré dans:
| Publié dans: | Int J Immunopathol Pharmacol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7262987/ https://ncbi.nlm.nih.gov/pubmed/32462951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2058738420923907 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|